Cholesterol metabolism in the brain
Top Cited Papers
- 1 April 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 12 (2) , 105-112
- https://doi.org/10.1097/00041433-200104000-00003
Abstract
The central nervous system accounts for only 2% of the whole body mass but contains almost a quarter of the unesterified cholesterol present in the whole individual. This sterol is largely present in two pools comprised of the cholesterol in the plasma membranes of glial cells and neurons and the cholesterol present in the specialized membranes of myelin. From 0.02% (human) to 0.4% (mouse) of the cholesterol in these pools turns over each day so that the absolute flux of sterol across the brain is only approximately 0.9% as rapid as the turnover of cholesterol in the whole body of these respective species. The input of cholesterol into the central nervous system comes almost entirely from in situ synthesis, and there is currently little evidence for the net transfer of sterol from the plasma into the brain of the fetus, newborn or adult. In the steady state in the adult, an equivalent amount of cholesterol must move out of the brain and this output is partly accounted for by the formation and excretion of 24S-hydroxycholesterol. This cholesterol turnover across the brain is increased in neurodegenerative disorders such as Alzheimer's disease and Niemann-Pick type C disease. Indirect evidence suggests that large amounts of cholesterol also turn over among the glial cells and neurons within the central nervous system during brain growth and neuron repair and remodelling. This internal recycling of sterol may involve ligands such as apolipoproteins E and AI, and one or more membrane transport proteins such as members of the low density lipoprotein receptor family. Changes in cholesterol balance across the whole body may, in some way, cause alterations in sterol recycling and apolipoprotein E expression within the central nervous system, which, in turn, may affect neuron and myelin integrity. Further elucidation of the processes controlling these events is very important to understand a variety of neurodegenerative disorders.Keywords
This publication has 65 references indexed in Scilit:
- Isolation and Characterization of Apolipoproteins from Murine MicrogliaJournal of Biological Chemistry, 2000
- Differences in effects of pravastatin and simvastatin (40 mg/day) on total serum cholesterol, 24s-hydroxycholesterol and 27-hydroxycholesterolAtherosclerosis, 2000
- The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's diseaseBrain Research Reviews, 1998
- Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxingJAMA, 1997
- Apolipoprotein E-containing High Density Lipoprotein Promotes Neurite Outgrowth and Is a Ligand for the Low Density Lipoprotein Receptor-related ProteinPublished by Elsevier ,1996
- Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor Mediates the Cellular Internalization and Degradation of ThrombospondinPublished by Elsevier ,1995
- Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse.Journal of Clinical Investigation, 1995
- Nerve Regeneration and Cholesterol Reutilization Occur in the Absence of Apolipoproteins E and A‐I in MiceJournal of Neurochemistry, 1995
- Cholesterol from Degenerating Nerve Myelin Becomes Associated with Lipoproteins Containing Apolipoprotein EJournal of Neurochemistry, 1991
- A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.Journal of Clinical Investigation, 1989